Bruker Corporation(BRKR)Earnings, Financials & Key Ratios

BRKR•NASDAQ

$42.30

$6.44B mkt cap·Price updated May 6, 2026

SectorHealthcare IndustryMedical Devices Sub-IndustryImaging, radiation, and oncology devices

AboutBruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.Show more

Revenue$3.44B+2.1%
EBITDA$456M+4.4%
Net Income-$9M-107.6%
EPS (Diluted)-0.15-119.7%
Gross Margin45.91%-6.3%
EBITDA Margin13.28%+2.3%
Operating Margin6.87%-8.7%
Net Margin-0.25%-107.5%
ROE-0.4%-105.7%
ROIC4.35%-29.1%
Debt/Equity0.81-34.2%
Interest Coverage1.36-74.3%

Technical→

BRKR Key Insights

Bruker Corporation (BRKR) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Strong 5Y sales CAGR of 11.6%

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

BRKR Price & Volume

Bruker Corporation (BRKR) stock price & volume — 10-year historical chart

Loading chart...

BRKR Growth Metrics

Bruker Corporation (BRKR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years7.79%

5 Years11.57%

3 Years10.74%

TTM0.36%

Profit CAGR

10 Years-

5 Years-

3 Years-

TTM-132.66%

EPS CAGR

10 Years-

5 Years-

3 Years-

TTM-146.54%

Return on Capital

10 Years13.53%

5 Years11.9%

3 Years8.96%

Last Year4.97%

BRKR Recent Earnings

Bruker Corporation (BRKR) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 8/12 qtrs (67%)●Beat Revenue 8/12 qtrs (67%)

Q2 2026Latest

May 6, 2026

EPS

$0.31

Est $0.23

+34.8%

Revenue

$823M

Est $796M

+3.5%

Q1 2026

Feb 12, 2026

EPS

$0.59

Est $0.65

-9.2%

Revenue

$977M

Est $962M

+1.6%

Q4 2025

Nov 3, 2025

EPS

$0.60

Est $0.33

+81.8%

Revenue

$861M

Est $965M

-10.8%

Q3 2025

Aug 4, 2025

EPS

$0.32

Est $0.33

-3.0%

Revenue

$797M

Est $810M

-1.6%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	May 6, 2026	$0.31vs $0.23+34.8%	$823Mvs $796M+3.5%
Q1 2026	Feb 12, 2026	$0.59vs $0.65-9.2%	$977Mvs $962M+1.6%
Q4 2025	Nov 3, 2025	$0.60vs $0.33+81.8%	$861Mvs $965M-10.8%
Q3 2025	Aug 4, 2025	$0.32vs $0.33-3.0%	$797Mvs $810M-1.6%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
WATWaters CorporationDirect Competitor	22.78B	349.53	32.48	6.99%	11.91%	8.04%	0.55
TRMBTrimble Inc.Direct Competitor	15.02B	63.42	36.24	-2.61%	12.37%	7.95%	0.24
FTVFortive CorporationDirect Competitor	18.59B	60.40	34.71	-17.48%	11.48%	7.38%	0.50
AAgilent Technologies, Inc.Product Competitor	33.31B	117.69	25.75	6.73%	18.26%	18.67%	0.50
TMOThermo Fisher Scientific Inc.Product Competitor	175.76B	472.95	26.66	3.91%	15.18%	13.23%	0.76
MTDMettler-Toledo International Inc.Product Competitor	27B	1328.15	31.50	3.98%	21.59%
ROPRoper Technologies, Inc.Product Competitor	36.05B	350.26	24.67	12.26%	21.12%	8.75%	0.47
DHRDanaher CorporationSupply Chain	123.8B	174.92	34.71	2.9%	14.89%	7.06%	0.35

Compare BRKR vs Peers

Bruker Corporation (BRKR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs WAT

Most directly comparable listed peer for BRKR.

Scale Benchmark

vs TMO

Larger-name benchmark to compare BRKR against a more recognizable public peer.

Peer Set

Compare Top 5

vs WAT, TRMB, FTV, A

BRKR Income Statement

Bruker Corporation (BRKR) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Sales/Revenue	1.77B	1.9B	2.07B	1.99B	2.42B	2.53B	2.96B	3.37B	3.44B	3.46B
Revenue Growth %	9.59%	7.34%	9.34%	-4.11%	21.66%	4.67%	17.14%	13.56%	2.08%	0.36%
Cost of Goods Sold	952.9M	995.6M	1.08B	1.05B	1.21B	1.23B	1.45B	1.72B	1.86B	1.89B
COGS % of Revenue	53.96%	52.52%	51.98%	52.71%	49.97%	48.41%	48.95%	51%	54.09%	-
Gross Profit	813M▲ 0%	900M▲ 10.7%	995.3M▲ 10.6%	939.8M▼ 5.6%	1.21B▲ 28.7%	1.31B▲ 7.9%	1.51B▲ 15.9%	1.65B▲ 9.0%	1.58B▼ 4.4%	1.57B▲ 0%
Gross Margin %	46.04%	47.48%	48.02%	47.29%	50.03%	51.59%	51.05%	49%	45.91%	45.29%
Gross Profit Growth %	9.49%	10.7%	10.59%	-5.58%	28.71%	7.94%	15.9%	9%	-4.35%	-
Operating Expenses	578.6M	618.1M	694.4M	691.5M	796.3M	873M	1.08B	1.4B	1.34B	1.4B
OpEx % of Revenue	32.77%	32.61%	33.5%	34.79%	32.93%	34.5%	36.31%	41.48%	39.04%	-
Selling, General & Admin	415.9M	444.7M	504.8M	477.8M	562.3M	607.4M	729.4M	893.8M	946.5M	963.2M
SG&A % of Revenue	23.55%	23.46%	24.36%	24.04%	23.26%	24%	24.6%	26.55%	27.54%	-
Research & Development	162.7M	173.4M	187.7M	198M	220.8M	235.9M	294.8M	376.5M	395.2M	399.4M
R&D % of Revenue	9.21%	9.15%	9.06%	9.96%	9.13%	9.32%	9.94%	11.18%	11.5%	-
Other Operating Expenses	0	0	1.9M	15.7M	13.2M	29.7M	52.2M	126.1M	0	2M
Operating Income	214.7M▲ 0%	262.4M▲ 22.2%	300.9M▲ 14.7%	248.3M▼ 17.5%	413.3M▲ 66.5%	432.7M▲ 4.7%	436.9M▲ 1.0%	253.1M▼ 42.1%	236M▼ 6.8%	168.9M▲ 0%
Operating Margin %	12.16%	13.84%	14.52%	12.49%	17.09%	17.1%	14.74%	7.52%	6.87%	4.88%
Operating Income Growth %	21.16%	22.22%	14.67%	-17.48%	66.45%	4.69%	0.97%	-42.07%	-6.76%	-
EBITDA	278.6M	327.3M	376.5M	328.7M	502.5M	521.4M	551.8M	436.9M	456.3M	338.8M
EBITDA Margin %	15.78%	17.27%	18.17%	16.54%	20.78%	20.6%	18.61%	12.98%	13.28%	9.8%
EBITDA Growth %	20.35%	17.48%	15.03%	-12.7%	52.88%	3.76%	5.83%	-20.82%	4.44%	-19.26%
D&A (Non-Cash Add-back)	63.9M	64.9M	75.6M	80.4M	89.2M	88.7M	114.9M	183.8M	220.3M	169.9M
EBIT	235.6M	275.2M	296.4M	240.2M	407.9M	430M	560.6M	254.8M	82.3M	44.1M
Net Interest Income	-14.6M	-11.4M	-14.7M	-11.2M	-13.4M	-13.3M	-8.9M	-38.6M	-45.5M	-44.3M
Interest Income	800K	1.2M	1.3M	3.2M	900K	2.8M	7.5M	9.3M	14.8M	2.9M
Interest Expense	15.4M	12.6M	16M	14.4M	14.3M	16.1M	16.4M	47.9M	60.3M	58.9M
Other Income/Expense	-21.7M	-17.7M	-20.5M	-22.5M	-19.7M	-17.8M	109.3M	-47.9M	-215M	-170.9M
Pretax Income	197.8M▲ 0%	244.7M▲ 23.7%	280.4M▲ 14.6%	225.8M▼ 19.5%	393.6M▲ 74.3%	414.9M▲ 5.4%	546.2M▲ 31.6%	205.2M▼ 62.4%	21M▼ 89.8%	-2M▲ 0%
Pretax Margin %	11.2%	12.91%	13.53%	11.36%	16.28%	16.39%	18.42%	6.1%	0.61%	-0.06%
Income Tax	117.5M	63.7M	82.4M	64.4M	113M	116.4M	117.7M	91.4M	29.3M	23.1M
Effective Tax Rate %	59.4%	26.03%	29.39%	28.52%	28.71%	28.05%	21.55%	44.54%	139.52%	-1155%
Net Income	78.6M▲ 0%	179.7M▲ 128.6%	197.2M▲ 9.7%	157.8M▼ 20.0%	277.1M▲ 75.6%	296.6M▲ 7.0%	427.2M▲ 44.0%	113.1M▼ 73.5%	-8.6M▼ 107.6%	-26M▲ 0%
Net Margin %	4.45%	9.48%	9.51%	7.94%	11.46%	11.72%	14.41%	3.36%	-0.25%	-0.75%
Net Income Growth %	-48.83%	128.63%	9.74%	-19.98%	75.6%	7.04%	44.03%	-73.53%	-107.6%	-132.66%
Net Income (Continuing)	80.3M	181M	198M	161.4M	280.6M	298.5M	428.5M	113.8M	-8.3M	-25.1M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	8.1M	8.5M	31.4M	13.1M	14.3M	18M	36.1M	34M	53.8M	35.8M
EPS (Diluted)	0.49▲ 0%	1.14▲ 132.7%	1.26▲ 10.5%	1.02▼ 19.0%	1.81▲ 77.5%	1.99▲ 9.9%	2.90▲ 45.7%	0.76▼ 73.8%	-0.15▼ 119.7%	-0.17▲ 0%
EPS Growth %	-48.42%	132.65%	10.53%	-19.05%	77.45%	9.94%	45.73%	-73.79%	-119.74%	-146.54%
EPS (Basic)	0.50	1.15	1.27	1.03	1.83	2.00	2.92	0.76	-0.15	-
Diluted Shares Outstanding	159.1M	157.2M	156.6M	154.6M	152.9M	149.4M	147.2M	149.5M	151.8M	152.7M
Basic Shares Outstanding	158.1M	156.2M	155.2M	153.4M	151.4M	148.6M	146.4M	149M	151.8M	152.2M
Dividend Payout Ratio	32.32%	13.97%	12.68%	15.59%	8.73%	10.05%	6.88%	26.7%	-	-

BRKR Balance Sheet

Bruker Corporation (BRKR) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Total Current Assets	1.36B	1.3B	1.8B	1.93B	2.47B	2.11B	2.16B	2.05B	2.21B	2.1B
Cash & Short-Term Investments	439.2M	322.4M	684.9M	731.8M	1.17B	645.5M	488.3M	183.4M	298.8M	133.4M
Cash Only	325M	322.4M	678.3M	681.8M	1.07B	645.5M	488.3M	183.4M	298.8M	133.4M
Short-Term Investments	114.2M	0	6.6M	50M	100M	0	0	0	0	0
Accounts Receivable	319.3M	357.2M	362.2M	335.3M	416.9M	595.3M	621.8M	701.2M	736M	542.7M
Days Sales Outstanding	66	68.78	63.79	61.58	62.93	85.86	76.56	76.03	78.17	73.46
Inventory	486.2M	509.6M	577.2M	692.3M	710.1M	800.1M	968.3M	1.07B	1.09B	1.12B
Days Inventory Outstanding	186.23	186.83	195.56	241.19	214.51	238.4	243.54	227.01	214.94	223.33
Other Current Assets	114.1M	115.1M	172M	165.6M	176.6M	29M	30.3M	39.6M	47.9M	306M
Total Non-Current Assets	589.7M	824.3M	975.2M	1.12B	1.18B	1.5B	2.09B	3.75B	4.03B	4.03B
Property, Plant & Equipment	266.5M	270.6M	371.7M	462.9M	466M	538.2M	691.4M	814.8M	910.6M	719.6M
Fixed Asset Turnover	6.63x	7.01x	5.58x	4.29x	5.19x	4.70x	4.29x	4.13x	3.77x	4.41x
Goodwill	169.8M	275.7M	293M	320.4M	339.5M	457.6M	582.6M	1.51B	1.55B	0
Intangible Assets	82.4M	218.7M	233.2M	229.1M	211.8M	270.9M	330.5M	912.5M	899.6M	0
Long-Term Investments	-71M	-59.3M	0	0	0	0	0	0	8.2M	16.1M
Other Non-Current Assets	14M	8.4M	16.8M	39.6M	70.8M	155.1M	184M	232.7M	241.1M	1.9B
Total Assets	1.95B▲ 0%	2.13B▲ 9.2%	2.77B▲ 30.2%	3.05B▲ 10.0%	3.65B▲ 19.7%	3.61B▼ 1.0%	4.25B▲ 17.7%	5.81B▲ 36.6%	6.24B▲ 7.5%	6.13B▲ 0%
Asset Turnover	0.91x	0.89x	0.75x	0.65x	0.66x	0.70x	0.70x	0.58x	0.55x	0.55x
Asset Growth %	7.48%	9.24%	30.2%	10.01%	19.71%	-1.05%	17.67%	36.63%	7.49%	23.49%
Total Current Liabilities	524.5M	598M	645.6M	791.9M	938.5M	914.3M	1.2B	1.28B	1.28B	1.36B
Accounts Payable	90.8M	104.5M	118.4M	134.6M	147.4M	178.4M	202.7M	234.1M	215.9M	269.1M
Days Payables Outstanding	34.78	38.31	40.12	46.89	44.53	53.16	50.98	49.77	42.39	44
Short-Term Debt	0	18.5M	500K	2.2M	112.4M	18.7M	121.2M	32.5M	51.8M	8.4M
Deferred Revenue (Current)	111.7M	124.4M	240.5M	307.2M	335.9M	370.2M	400M	438.2M	441.3M	1.4B
Other Current Liabilities	256.3M	288.5M	119.5M	121.3M	156.4M	159.9M	218.3M	300.3M	302.8M	867M
Current Ratio	2.59x	2.18x	2.78x	2.43x	2.63x	2.31x	1.80x	1.60x	1.73x	1.73x
Quick Ratio	1.66x	1.33x	1.89x	1.56x	1.88x	1.44x	0.99x	0.77x	0.87x	0.87x
Cash Conversion Cycle	217.45	217.29	219.23	255.87	232.91	271.1	269.12	253.27	250.72	252.78
Total Non-Current Liabilities	690.5M	625.5M	1.19B	1.28B	1.63B	1.57B	1.63B	2.71B	2.45B	2.31B
Long-Term Debt	415.6M	322.6M	812.8M	842.3M	1.22B	1.2B	1.16B	2.06B	1.69B	1.66B
Capital Lease Obligations	1.3M	7.1M	47M	47M	41.8M	34.8M	74.8M	118.9M	296.6M	296.6M
Deferred Tax Liabilities	24.3M	51.1M	48.8M	43.1M	46M	62.3M	67.7M	118.5M	112.5M	112.5M
Other Non-Current Liabilities	200.6M	182.5M	236.3M	299.5M	266.9M	166.5M	240.2M	311M	239.2M	2.32B
Total Liabilities	1.22B	1.22B	1.83B	2.07B	2.57B	2.48B	2.84B	3.99B	3.73B	3.66B
Total Debt	415.6M	341.1M	880.9M	912.8M	1.39B	1.27B	1.38B	2.25B	2.04B	1.67B
Net Debt	90.6M	18.7M	202.6M	231M	325.7M	624.9M	891.3M	2.06B	1.74B	1.54B
Debt / Equity	0.56x	0.37x	0.94x	0.94x	1.28x	1.12x	0.98x	1.24x	0.81x	0.81x
Debt / EBITDA	1.49x	1.04x	2.34x	2.78x	2.77x	2.44x	2.50x	5.14x	4.48x	4.93x
Net Debt / EBITDA	0.33x	0.06x	0.54x	0.70x	0.65x	1.20x	1.62x	4.72x	3.82x	3.82x
Interest Coverage	15.30x	21.84x	18.53x	16.68x	28.52x	26.71x	34.18x	5.32x	1.36x	0.75x
Total Equity	741.6M▲ 0%	913.6M▲ 23.2%	938.2M▲ 2.7%	974.3M▲ 3.8%	1.08B▲ 11.3%	1.13B▲ 4.3%	1.41B▲ 24.9%	1.82B▲ 28.4%	2.51B▲ 38.3%	2.5B▲ 0%
Equity Growth %	5.97%	23.19%	2.69%	3.85%	11.34%	4.33%	24.87%	28.44%	38.29%	111.04%
Book Value per Share	4.66	5.81	5.99	6.30	7.09	7.58	9.60	12.14	16.54	16.39
Total Shareholders' Equity	733.5M	905.1M	906.8M	961.2M	1.07B	1.11B	1.38B	1.78B	2.46B	2.47B
Common Stock	1.7M	1.7M	1.7M	1.7M	1.7M	1.7M	1.7M	1.8M	1.8M	0
Retained Earnings	942M	1.1B	1.27B	1.41B	1.66B	1.93B	2.32B	2.41B	2.36B	0
Treasury Stock	-401.2M	-401.5M	-543.8M	-667M	-820.3M	-1.08B	-1.24B	-1.24B	-1.24B	0
Accumulated OCI	27M	17M	-25.5M	3.7M	-8.2M	14.8M	6M	-103.5M	-79.5M	0
Minority Interest	8.1M	8.5M	31.4M	13.1M	14.3M	18M	36.1M	34M	53.8M	35.8M

BRKR Cash Flow Statement

Bruker Corporation (BRKR) cash flow — operating, investing & free cash flow history

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Cash from Operations	154.4M	239.7M	213.4M	332.2M	282.4M	274.4M	350.1M	251.3M	134.1M	134.1M
Operating CF Margin %	8.74%	12.65%	10.3%	16.71%	11.68%	10.84%	11.81%	7.46%	3.9%	-
Operating CF Growth %	18.04%	55.25%	-10.97%	55.67%	-14.99%	-2.83%	27.59%	-28.22%	-46.64%	-11846.88%
Net Income	80.3M	181M	198M	161.4M	280.6M	298.5M	427.2M	113.8M	29.2M	-26M
Depreciation & Amortization	63.9M	64.9M	75.6M	80.5M	89.1M	88.7M	114.9M	183.8M	220.3M	228.2M
Stock-Based Compensation	11M	11.3M	9.6M	16M	17.2M	27.7M	24M	25.3M	0	0
Deferred Taxes	28.2M	-15.1M	-5.4M	-22.5M	-5.8M	-14.8M	-24.4M	-63.8M	-104.5M	-81.8M
Other Non-Cash Items	11.6M	39.8M	10.1M	27.2M	26.5M	18.4M	-103.8M	70.4M	133.7M	200.6M
Working Capital Changes	-40.6M	-42.2M	-74.5M	69.6M	-125.2M	-144.1M	-87.8M	-78.2M	-144.6M	-197.3M
Change in Receivables	-55.5M	-30.5M	-5M	40.8M	-95.3M	-67.9M	-900K	-40.6M	0	0
Change in Inventory	-6.6M	-35.5M	-60.2M	-91.6M	-67M	-137.9M	-125M	-69.8M	0	-47.2M
Change in Payables	33.7M	6.2M	15.9M	-2.4M	61.8M	33.3M	23.1M	20.8M	-86M	11.2M
Cash from Investing	-30.2M	-123.4M	-158.4M	-192.7M	-192.4M	-251.6M	-326M	-1.76B	-196.5M	-210.1M
Capital Expenditures	-43.7M	-49.2M	-73M	-97.2M	-92M	-129.2M	-106.9M	-115.3M	-90.8M	-89M
CapEx % of Revenue	2.47%	2.6%	3.52%	4.89%	3.81%	5.11%	3.61%	3.43%	2.64%	-
Acquisitions	-66.3M	-191.6M	-90M	-59.2M	-65M	-182.3M	-226.6M	-1.6B	-73.9M	-88.8M
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	11.5M	118.9M	11M	200K	4.9M	13.9M	11.1M	1.1M	-31.8M	-32.3M
Cash from Financing	-159M	-112.4M	300M	-161.6M	318.7M	-415.3M	-193.4M	1.23B	135.1M	-18.6M
Debt Issued (Net)	3.1M	-93.5M	467M	-8.3M	489.7M	-110.7M	-21.5M	875.9M	-491.3M	-459.1M
Equity Issued (Net)	-152.2M	9.4M	-131.4M	-119.9M	-146.3M	-263.1M	-142.8M	403M	659.7M	-5.5M
Dividends Paid	-25.4M	-25.1M	-25M	-24.6M	-24.2M	-29.8M	-29.4M	-30.2M	-22.8M	-36.2M
Share Repurchases	-152.2M	0	-142.3M	-123.2M	-153.3M	-263.1M	-152.3M	0	-10M	0
Other Financing	15.5M	-3.2M	-10.6M	-8.8M	-500K	-11.7M	300K	-18.9M	-10.5M	482.2M
Net Change in Cash	-17M▲ 0%	-2.6M▲ 84.7%	355.6M▲ 13776.9%	3.6M▼ 99.0%	386.2M▲ 10627.8%	-423M▼ 209.5%	-157.1M▲ 62.9%	-304.9M▼ 94.1%	116.4M▲ 138.2%	-50.1M▲ 0%
Free Cash Flow	110.7M▲ 0%	190.5M▲ 72.1%	140.4M▼ 26.3%	235M▲ 67.4%	190.4M▼ 19.0%	145.2M▼ 23.7%	243.2M▲ 67.5%	136M▼ 44.1%	43.3M▼ 68.2%	51.3M▲ 0%
FCF Margin %	6.27%	10.05%	6.77%	11.82%	7.87%	5.74%	8.2%	4.04%	1.26%	1.48%
FCF Growth %	18.14%	72.09%	-26.3%	67.38%	-18.98%	-23.74%	67.49%	-44.08%	-68.16%	-70.62%
FCF per Share	0.70	1.21	0.90	1.52	1.25	0.97	1.65	0.91	0.29	0.29
FCF Conversion (FCF/Net Income)	1.96x	1.33x	1.08x	2.11x	1.02x	0.93x	0.82x	2.22x	-15.59x	-1.97x
Interest Paid	15.2M	11.7M	16M	28.7M	19.6M	24.3M	33.7M	54.6M	0	14.7M
Taxes Paid	53.1M	60.5M	61.3M	43M	145.5M	147.4M	96.6M	153.9M	0	38.7M

BRKR Key Ratios

Bruker Corporation (BRKR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM
Return on Equity (ROE)	10.91%	21.71%	21.3%	16.5%	26.91%	26.76%	33.57%	7.01%	-0.4%	-1.11%
Return on Invested Capital (ROIC)	20.11%	22.31%	21.77%	15.88%	23.7%	20.49%	16.14%	6.14%	4.35%	4.35%
Gross Margin	46.04%	47.48%	48.02%	47.29%	50.03%	51.59%	51.05%	49%	45.91%	45.29%
Net Margin	4.45%	9.48%	9.51%	7.94%	11.46%	11.72%	14.41%	3.36%	-0.25%	-0.75%
Debt / Equity	0.56x	0.37x	0.94x	0.94x	1.28x	1.12x	0.98x	1.24x	0.81x	0.81x
Interest Coverage	15.30x	21.84x	18.53x	16.68x	28.52x	26.71x	34.18x	5.32x	1.36x	0.75x
FCF Conversion	1.96x	1.33x	1.08x	2.11x	1.02x	0.93x	0.82x	2.22x	-15.59x	-1.97x
Revenue Growth	9.59%	7.34%	9.34%	-4.11%	21.66%	4.67%	17.14%	13.56%	2.08%	0.36%

BRKR SEC Filings & Documents

Bruker Corporation (BRKR) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

May 6, 2026·SEC

Material company update

Apr 28, 2026·SEC

Material company update

Apr 10, 2026·SEC

10-K Annual Reports

FY 2026

Feb 27, 2026·SEC

FY 2025

Mar 3, 2025·SEC

FY 2024

Feb 29, 2024·SEC

10-Q Quarterly Reports

FY 2025

Nov 5, 2025·SEC

FY 2025

Aug 6, 2025·SEC

FY 2025

May 7, 2025·SEC

BRKR Frequently Asked Questions

Bruker Corporation (BRKR) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Bruker Corporation (BRKR) reported $3.46B in revenue for fiscal year 2025. This represents a 5246% increase from $64.7M in 1999.

Bruker Corporation (BRKR) grew revenue by 2.1% over the past year. Growth has been modest.

Bruker Corporation (BRKR) reported a net loss of $26.0M for fiscal year 2025.

Dividend & Returns

Yes, Bruker Corporation (BRKR) pays a dividend with a yield of 0.36%. This makes it attractive for income-focused investors.

Bruker Corporation (BRKR) has a return on equity (ROE) of -0.4%. Negative ROE indicates the company is unprofitable.

Bruker Corporation (BRKR) generated $51.3M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More BRKR

Bruker Corporation (BRKR) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Bruker Corporation(BRKR)Earnings, Financials & Key Ratios

BRKR Key Insights

✓Strengths

✗Weaknesses

BRKR Price & Volume

BRKR Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

BRKR Recent Earnings

BRKR Peer Comparison

Compare BRKR vs Peers

vs WAT

vs TMO

Compare Top 5

BRKR Income Statement

BRKR Balance Sheet

BRKR Cash Flow Statement

BRKR Key Ratios

BRKR SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

BRKR Frequently Asked Questions

Explore More BRKR

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation